US Stock Research, Analysis & Valuation

Stock Insight

Circle Is Paying $400 Million for Tazapay. Why CRCL Stock Fell—and What the Deal Could Mean

Circle’s $400 million all-stock acquisition of Tazapay could accelerate its push into global payments, but dilution, regulatory risk and a still-premium CRCL valuation remain key concerns.

Stock Insight

WaFd’s EverBank Merger Could Boost 2027 EPS by 29%. Here’s What WAFD Investors Need to Know

WaFd’s merger with EverBank will heavily dilute existing shareholders, but management expects the larger bank to deliver 29% EPS accretion in 2027 and substantial cost synergies.

Stock Insight

Boston Scientific Could Cut Its 2026 Outlook for a Third Time. Is BSX Stock Finally Cheap?

Boston Scientific may cut its 2026 outlook for a third time after a cyberattack disrupted operations, but BSX’s steep selloff and lower valuation could be creating an opportunity.

Earnings Digest

Virco’s Profit Slumps, but the Stock Rallies. Here’s What Investors Should Watch Next

Virco shares rallied despite a sharp drop in first-half profit as quarterly results beat expectations, backlog improved, and investors looked ahead to a potential recovery in 2027.